The effect of the rules will be to add severe combined immunodeficiency disorder (SCID) to the mandated newborn screening panel and ensure NBS specimens will not be used for any purpose other than for newborn screening for which they were collected. Deletions will remove language conflicting with current protocols and standard operating procedures for the services of a centralized designated contract laboratory for newborn screening.
No specific cites listed — see the package documents.